1. bookVolume 72 (2022): Issue 1 (March 2022)
Journal Details
License
Format
Journal
eISSN
1820-7448
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
access type Open Access

Development and Validation of an Improved HPLC-UV Method for the Determination of Tildipirosin in Horse Plasma

Published Online: 05 Apr 2022
Volume & Issue: Volume 72 (2022) - Issue 1 (March 2022)
Page range: 100 - 110
Received: 28 Sep 2021
Accepted: 08 Mar 2022
Journal Details
License
Format
Journal
eISSN
1820-7448
First Published
25 Mar 2014
Publication timeframe
4 times per year
Languages
English
Abstract

A simple, rapid, low-cost, and sensitive high-performance liquid chromatographic method was developed to determine tildipirosin in horse plasma. Plasma samples were extracted with diethyl ether, and after evaporation, tildipirosin was determined by reverse-phase chromatography with an ultraviolet detector set at a wavelength of 289 nm. Tildipirosin was separated on a Zorbax Eclipse XDB-C18 column, 150 x 3.0 mm, 5 μm with gradient chromatographic elution. The retention times were 3.0 min and 6.4 min for tildipirosin and tylosin tartrate, respectively. The total run time was 9 minutes in this method.

Calibration curves ranged from 0.1 to 3 μg/mL. The lower limit of detection for plasma was0.035μg/mL, and the lower limit of quantitation was 0.1 μg/mL. Both accuracy and precision were always < 12% exce pt for LLOQ < 20%. Mean recovery was 99.5 %. This procedure can be applied to determine tildipirosin concentrations in plasma and be useful to perform pharmacokinetic studies.

Keywords

1. Sengupta S, Chattopadhyay MK, Grossart, HP: The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol 2013, 4 (47).10.3389/fmicb.2013.00047359498723487476 Search in Google Scholar

2. Capita R, Alonso-Calleja C: Antibiotic-Resistant Bacteria: A Challenge for the Food Industry. Crit Rev Food Sci Nutr 2013, 53: 11–48.10.1080/10408398.2010.51983723035919 Search in Google Scholar

3. Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP, Teillant A, Laxminarayan R: Global trends in Antimicrobial use in food animals. Proc Natl Acad Sci 2015, 112: 5649–5654.10.1073/pnas.1503141112442647025792457 Search in Google Scholar

4. WHO. Global Action Plan on Antimicrobial Resistance; World Health Organization: Geneva, Switzerland, 2015. Search in Google Scholar

5. EMA (2016). Available online: https://www.ema.europa.eu/en/medicines/veterinary/EPAR/zuprevo#authorisationdetails-section (accessed on 16 March 2021) Search in Google Scholar

6. Menge M, Rose M, Bohland C, Zschiesche E, Kilp S, Metz W, et al: Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle). J Vet Pharmacol Ther 2012, 35: 550–559.10.1111/j.1365-2885.2011.01349.x22188102 Search in Google Scholar

7. Rose M, Menge M, Bohland C, Zschiesche E, Wilhelm C, Kilp S, et al: Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae. J Vet Pharmacol Ther 2013, 36 (2): 140–153.10.1111/j.1365-2885.2012.01397.x22500881 Search in Google Scholar

8. Wang J, Zhao T, Sun X, Liu Y, Zhu J, Zhang S, et al: Pharmacokinetics of tildipirosin in beagle dogs. J Vet Pharmacol Ther 2018, 41 (1): e49–e52.10.1111/jvp.1245328892155 Search in Google Scholar

9. Xiong J, Xu Y, He S, Zhang Y, Wang Z, Wang S, Jiang H: Pharmacokinetics and bioavailability of tildipirosin in rabbits following single-dose intravenous and intramuscular administration. J Vet Pharmacol Ther 2020, 43: 448–453.10.1111/jvp.1288232542744 Search in Google Scholar

10. Galecio JS, Escudero E, Cerón JJ, Crescenzo G, Marín P: Pharmacokinetics of tildipirosin in ewes after intravenous, intramuscular and subcutaneous administration. Animals 2020, 10: 1332.10.3390/ani10081332746042032752202 Search in Google Scholar

11. Arsic B, Barber J, Č ikoš A, Mladenovic M, Stankovic N, Novak P: 16-membered macrolide antibiotics: a review. Int J Antimicrob Agents 2018, 51(3): 283-298.10.1016/j.ijantimicag.2017.05.02028668674 Search in Google Scholar

12. Zeng D, Sun M, Lin Z, Li M, Gehring R, Zeng Z: Pharmacokinetics, and pharmacodynamics of tildipirosin against Pasteurella multocida in a murine lung infection model. Front Microbiol 2018, 9, 1038.10.3389/fmicb.2018.01038596819329867911 Search in Google Scholar

13. Abu-Basha EA, Bani Ismail Z, Abu Alhaijaa H, Hamzeh E, Idkaidek NM: Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in sheep. J Vet Pharmacol Ther 2021, 44: 79–85.10.1111/jvp.1290132748450 Search in Google Scholar

14. Lei Z, Liu Q, Yang B, Ahmed S, Cao J, He Q: The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis. Oncotarget 2018, 9: 1673-1690.10.18632/oncotarget.23018578859029416722 Search in Google Scholar

15. Elazab ST, Badawy ME: Pharmacokinetics and bioavailability of tildipirosin in goats using HPLC. JJVR 2020, 68 (1): 5-12. Search in Google Scholar

16. Abu-Basha EA, Bani Ismail Z, Ababneh MM, Hamzeh E, Gehring R: Pharmacokinetics and bioavailability of tildipirosin following intravenous and subcutaneous administration in horses. J Vet Pharmacol Ther 2021, 44: 544-551.10.1111/jvp.1295833609061 Search in Google Scholar

17. Food and Drug Administration. U.S. Department of Health and Human Services, Bioanalytical Method Validation Guidance for Industry., U.S. Dep. Heal. Hum. Serv. Food Drug Adm. (2018) 1–41. https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf Search in Google Scholar

18. Wang J, Leung D, Chow W, Chang J, Wong JW: Target screening of 105 veterinary drug residues in milk using UHPLC/ESI Q-Orbitrap multiplexing data independent acquisition. Anal Bional Chem 2018, 410: 5373-5389.10.1007/s00216-017-0847-z29404665 Search in Google Scholar

19. Castilla-Fernández D, Moreno-González D, Beneito-Cambra M, Molina-Díaz A: Critical assessment of two sample treatment methods for multiresidue determination of veterinary drugs in milk by UHPLC-MS/MS. Anal Bional Chem 2019, 41: 1433-1442.10.1007/s00216-019-01582-y30683965 Search in Google Scholar

20. Wang H, Ren L, Yu X, Hu J, Chen Y, He G, Jiang Q: Antibiotic residues in meat, milk and aquatic products in Shanghai and human exposure assessment. Food Cont 2017, 80: 217-225.10.1016/j.foodcont.2017.04.034 Search in Google Scholar

21. Zhou W, Yang S, Wang P G: Matrix effects and aplication of matrix effect factor. Bioanalysis 2017, 9 (23): 1839-1844.10.4155/bio-2017-021429171768 Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo